Skip to main content
40°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
The AI Race Gets Litigious
March 09, 2024
Tickers
AAPL
ABBV
AMGN
AXON
Tags
CRM
AXON
ABBV
From
Motley Fool
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
Tickers
ABBV
BGNE
GILD
NEWS
Tags
Health Care
RHHBY
FDA
From
Benzinga
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
March 07, 2024
Tickers
ACLX
BMY
GILD
JNJ
Tags
BMY
Analyst Ratings
Stories That Matter
From
Benzinga
Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead's and Merck's Combo Therapy
March 06, 2024
Tickers
GILD
MRK
NEWS
Tags
Health Care
Large Cap
News
From
Benzinga
Biogen's Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers
March 06, 2024
Tickers
BIIB
GILD
MRK
NEWS
Tags
MRK
Stories That Matter
BIIB
From
Benzinga
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
March 04, 2024
Tickers
ACB
ANGO
APA
BNTX
Tags
FNV
XEL
NASDAQ:GILD,NYSE:FNV,NASDAQ:XEL,NASDAQ:BNTX,NYSE:PFE,NASDAQ:APA,NASDAQ:ACB,NASDAQ:ANGO
From
InvestorPlace
Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges
March 04, 2024
Tickers
GILD
GSK
NEWS
PFE
Tags
Biden Administration
Health Care
Benzinga
From
Benzinga
3 Dividend Stocks That Are No-Brainer Buys Right Now
February 24, 2024
Tickers
ABBV
GILD
LLY
Tags
Market News
Recent Press Releases
ABBV
From
Motley Fool
History Says the Nasdaq Will Keep Soaring in 2024 -- and Wall Street Thinks This High-Yield Dividend Stock Could Jump Nearly 20%
February 24, 2024
Tickers
GILD
Tags
Market News
Recent Press Releases
GILD
From
Motley Fool
$1000 Invested In This Stock 20 Years Ago Would Be Worth $11,000 Today
February 23, 2024
Tickers
GILD
NEWS
Tags
GILD
BZI/POD
Market News
From
Benzinga
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
February 22, 2024
Tickers
ALT
AMGN
BIIB
GILD
Tags
VKTX
NASDAQ:VRTX,NASDAQ:AMGN,NASDAQ:GILD,NASDAQ:BIIB,NASDAQ:PYXS,NASDAQ:VKTX,NASDAQ:ALT
VRTX
From
InvestorPlace
Stock Alert: 3 Market Giants on the Brink of Monumental Rallies
February 20, 2024
Tickers
GILD
GT
PYPL
Tags
PYPL
GT
NASDAQ:GT,NASDAQ:PYPL,NASDAQ:GILD
From
InvestorPlace
From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024
February 19, 2024
Tickers
AGCO
BIIB
BTG
GILD
Tags
PM
SMCI
Stocks to Buy
From
InvestorPlace
Why Is Gilead Sciences Stock Trading Lower Today?
February 16, 2024
Tickers
GILD
NEWS
Tags
why it's moving
Health Care
Movers
From
Benzinga
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
Tickers
AMGN
AZN
BIIB
BMY
Tags
NVS
Stocks to Buy
BMY
From
InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
February 14, 2024
Tickers
BMY
GILD
NEWS
PFE
Tags
Benzinga
News
General
From
Benzinga
CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
February 13, 2024
Tickers
CBAY
GILD
ICPT
NEWS
Tags
GILD
Equities
Biotech
From
Benzinga
Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
February 12, 2024
Tickers
ANTX
BIG
BMR
CBAY
Tags
News
ANTX
Eurozone
From
Benzinga
Health Care Company Gilead Sciences Announces Acquisition of CymaBay Therapeutics
February 12, 2024
Tickers
CBAY
GILD
NEWS
Tags
Benzinga
News
BZI/MA
From
Benzinga
Drugmaker Gilead Sciences Scoops Up Liver-Disease Focused CymaBay Therapeutics For $4.3B
February 12, 2024
Tickers
CBAY
GILD
NEWS
Tags
M&A
why it's moving
Health Care
From
Benzinga
Top 5 Health Care Stocks That Are Preparing To Pump In February
February 09, 2024
Tickers
BIOL
CNSP
GILD
NEWS
Tags
RSI
Market News
GILD
From
Benzinga
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
Tickers
AGIO
ALKS
ARWR
BIIB
Tags
Market News
BMRN
GILD
From
InvestorPlace
Why Gilead Sciences Stock Dropped Today
February 07, 2024
Tickers
GILD
Tags
Market News
Recent Press Releases
GILD
From
Motley Fool
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
February 07, 2024
Tickers
AAPL
AMGN
AMZN
CMG
Tags
Intraday Update
Analyst Ratings
AAPL
From
Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $10,000 Today
February 07, 2024
Tickers
GILD
NEWS
Tags
Trading Ideas
News
Benzinga
From
Benzinga
2 Beaten-Down Dividend Stocks to Buy Hand Over Fist
February 07, 2024
Tickers
EBAY
GILD
Tags
Recent Press Releases
Market News
GILD
From
Motley Fool
Gilead Sciences (GILD) Q4 2023 Earnings Call Transcript
February 06, 2024
Tickers
GILD
Tags
Recent Press Releases
Market News
GILD
From
Motley Fool
Why Gilead Sciences Stock Is Trading Lower After The Bell
February 06, 2024
Tickers
GILD
NEWS
Tags
GILD
Market News
why it's moving
From
Benzinga
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
February 06, 2024
Tickers
AMGN
BP
CCK
CMG
Tags
FXI
XLK
XLY
From
Benzinga
Earnings Scheduled For February 6, 2024
February 06, 2024
Tickers
AAT
AB
ACT
AEIS
Tags
HTZ
NBR
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.